Safety And Efficacy Of Abivertinib (Ac0010), A Third-Generation Egfr Tyrosine Kinase Inhibitor, In Chinese Patients With Egfr-T790m Positive Non-Small Cell Lung Cancer (Ncslc).
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要